These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2449306)

  • 21. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.
    Bengtsson AA; Sturfelt G; Truedsson L; Blomberg J; Alm G; Vallin H; Rönnblom L
    Lupus; 2000; 9(9):664-71. PubMed ID: 11199920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of interferons-alpha and -gamma in renal lesions of systemic lupus erythematosus and membranous glomerulonephritis.
    Husby G; Williams RC; Ramirez F; Tung KS
    Clin Immunol Immunopathol; 1986 Apr; 39(1):68-80. PubMed ID: 3081289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
    Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
    J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
    Ytterberg SR; Schnitzer TJ
    Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus.
    Ahn SS; Park ES; Shim JS; Ha SJ; Kim BS; Jung SM; Lee SW; Park YB; Song JJ
    Arthritis Res Ther; 2017 Aug; 19(1):193. PubMed ID: 28841837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of anti-interferon antibodies in systemic lupus erythematosus.
    Suit BE; Axelrod D; Moutsopoulos HM; Decker JL; Hooks JJ
    Clin Exp Rheumatol; 1983; 1(2):133-5. PubMed ID: 6442634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus.
    Han BK; Wysham KD; Cain KC; Tyden H; Bengtsson AA; Lood C
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32444416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus.
    Kok HM; van den Hoogen LL; van Roon JAG; Adriaansen EJM; Fritsch-Stork RDE; Nguyen TQ; Goldschmeding R; Radstake TRDJ; Bovenschen N
    Rheumatology (Oxford); 2017 Dec; 56(12):2129-2134. PubMed ID: 28968826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
    Merrill JT; Wallace DJ; Petri M; Kirou KA; Yao Y; White WI; Robbie G; Levin R; Berney SM; Chindalore V; Olsen N; Richman L; Le C; Jallal B; White B;
    Ann Rheum Dis; 2011 Nov; 70(11):1905-13. PubMed ID: 21798883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.
    Lu CL; Tsai ST; Chan CY; Hwang SJ; Tsai CY; Wu JC; Lu RH; Lin BC; Lee SD
    J Gastroenterol Hepatol; 1997 Apr; 12(4):272-6. PubMed ID: 9195365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
    Yoshikawa M; Nakayamada S; Kubo S; Nawata A; Kitanaga Y; Iwata S; Sakata K; Ma X; Wang SP; Nakano K; Saito K; Tanaka Y
    Clin Immunol; 2019 Mar; 200():1-9. PubMed ID: 30576845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of serum interferon with some clinical and humoral signs of systemic lupus erythematosus.
    Matei I; Ghyka G; Savi I; Tudor A
    Med Interne; 1990; 28(4):289-94. PubMed ID: 1713346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.
    Welcher AA; Boedigheimer M; Kivitz AJ; Amoura Z; Buyon J; Rudinskaya A; Latinis K; Chiu K; Oliner KS; Damore MA; Arnold GE; Sohn W; Chirmule N; Goyal L; Banfield C; Chung JB
    Arthritis Rheumatol; 2015 Oct; 67(10):2713-22. PubMed ID: 26138472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
    Batteux F; Palmer P; Daëron M; Weill B; Lebon P
    Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
    Lood C; Tydén H; Gullstrand B; Klint C; Wenglén C; Nielsen CT; Heegaard NH; Jönsen A; Kahn R; Bengtsson AA
    PLoS One; 2015; 10(4):e0125109. PubMed ID: 25897671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-gamma and immune complex.
    Arora V; Mondal AM; Grover R; Kumar A; Chattopadhyay P; Das N
    Mol Immunol; 2007 Mar; 44(7):1722-8. PubMed ID: 17049990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.